HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
4505studies shown
Showing 349-360 of 4,505
Drug study icon
RecruitingNCT04478838

"Extended" (Alternate Day) Antipsychotic Dosing

Official study title

"Re-examining Maintenance Antipsychotic Treatment in Schizophrenia: "Extended" Antipsychotic Dosing"

In Toronto
SchizophreniaMedication studyAges 18+
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Drug study icon
RecruitingNCT07369154

52-week Open Label Safety-Tolerability Study

What is this study about?

This study evaluates the safety of LB-102 for people with schizophrenia.

Multiple locations, including Chandler
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
LB Pharmaceuticals Inc.
Drug study icon
RecruitingNCT07615426

Aticaprant for schizophrenia

What is this study about?

This study evaluates the safety of Aticaprant for people with schizophrenia.

Multiple locations, including Garden Grove
SchizophreniaMedication studyAges 18–60
Countries
United States
Sponsor
Janssen Research & Development, LLC
Drug study icon
RecruitingNCT07221877

Effect of KarXT on Urological Safety

Official study title

A 12-month Open-label, Phase 4 Multicenter Safety Study to Evaluate the Effect of KarXT on Voiding Dynamics and Urological Safety

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Bristol-Myers Squibb (Pharmaceutical company)
Other study type icon
RecruitingNCT07411222

Emotional Eating, Sleep Quality, Mental State and Metabolic Syndrome

Official study title

The Mediating Role of Emotional Eating and Sleep Quality in the Relationship Between Mental State and Metabolic Syndrome in Individuals With Schizophrenia and Bipolar Disorder

In Bolu
Schizophrenia, BipolarityObservational studyAges 18–65
Countries
Türkiye
Sponsor
Abant Izzet Baysal University
Other study type icon
RecruitingNCT05116514

Case management after a first psychotic episode in young people

About this title

Evaluation of the Impact of Case Manager Intervention on the 3-year Psychotic Episode Recurrence Rate in Patients Aged 16 to 30 Years With a First Psychotic Episode.

Read the official source — NCT05116514
Official study title

Evaluation of the Impact of Case Manager Intervention on the 3-year Psychotic Episode Recurrence Rate in Patients Aged 16 to 30 Years With a First Psychotic Episode. Randomized, Open-label, Multicenter Controlled Study With Blinded Evaluation.

Multiple locations, including Montpellier
SchizophreniaInterventional studyAges 16–30
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Device study icon
RecruitingNCT05783063

iTBS for Increased Appetite Induced by Antipsychotics

Official study title

Effects of Intermittent Theta Burst Stimulation (iTBS) on Increased Appetite Induced by Antipsychotics in Patients With Schizophrenia

In Dali
SchizophreniaDevice studyAges 18–40
Countries
China
Sponsor
Central South University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.